MedPath

Role of Individualized Homoeopathic medicine in Chronic Kidney Disease

Phase 2
Conditions
Health Condition 1: N189- Chronic kidney disease, unspecified
Registration Number
CTRI/2024/04/066441
Lead Sponsor
ational Institute of Homoeopathy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

a)Patient attending NIH outpatient or inpatient ward who is suffering from chronic kidney disease

b)Patient age group 30 to 75 years, of any gender, of any religion, of any socio-economic background

c)Patients must know Hindi, English or Bengali

d)eGFR less than 90ml per min per 1.73m2

e)Serum Creatinine greater than 1.5mg/dl

f)Serum Urea greater than 40mg/dl

g)The patient should be willing to give written consent

h)Patients willing to do all necessary laboratory tests as required

Exclusion Criteria

a)Patients undergoing dialysis

b)Patients with End-stage renal disease, with very advanced pathology

c)Subjects who are suffering from chronic renal failure as a result of malignant metastasis from other primary focus

d)Post renal transplant patients

e)Pregnant and lactating women

f)Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness

g)Substance abuse and/or dependence

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath